Professor Mark Hull is Professor of Molecular Gastroenterology, and Honorary Consultant Gastroenterologist at the University of Leeds. He has a general gastroenterology practice including management of inflammatory bowel disease.
Mark trained in Cambridge and Oxford and then obtained the PhD degree from the University of Nottingham studying gastric ulceration. He has held a number of prestigious research awards in the field of cancer chemoprevention including a MRC Clinician Scientist Award and MRC Senior Fellowship.
He has been Chair of the British Society of Gastroenterology Research Committee responsible for the Society’s Research Strategy.
As an expert on colorectal cancer prevention, he runs a laboratory programme and leads clinical trials on chemoprevention agents. He was Chair of the NCRI Clinical Studies Group on CRC screening & prevention and sits on multiple Trial and NIHR Committees.